Sevion Therapeutics Inc Share Price OTC Bulletin Board
Equities
US81834Q1040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.81M 219M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.09
x | P/E ratio 2024 * |
-0.1
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Sevion Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 31/10/20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 07/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 30/04/14 |
Alan Walts
BRD | Director/Board Member | 64 | 31/03/21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
1st Jan change | Capi. | |
---|---|---|
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |